文献速递甲状腺疾病

分化型甲状腺癌脑转移:临床表现、诊断与治疗

Brain Metastases in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis, and Management.
PubMed 文献 · Thyroid · 2024-09-04

本文为叙述性综述,讨论分化型甲状腺癌脑转移的临床特征、诊断与治疗选择。脑转移多在随访中经影像学或神经症状发现,增强磁共振成像为检测金标准;治疗策略仍有争议,神经外科手术可能带来最高生存获益,立体定向放射外科适用于特定患者,全脑放疗因副作用及疗效争议较少使用。

要点

  • 脑转移多在随访中因启动酪氨酸激酶抑制剂前影像或神经症状而诊断。
  • 增强磁共振成像是检测脑转移的金标准,优于增强计算机断层扫描。
  • 适合神经外科手术的患者似乎生存获益最高,立体定向放射外科可能适用于特定患者。

核心结论

  • 尽管不推荐常规筛查脑转移,但老年男性、滤泡性甲状腺癌或低分化甲状腺癌且伴远处转移的患者风险可能较高,应仔细评估脑转移。
  • 根据现有数据,适合神经外科手术的患者似乎生存获益最高,立体定向放射外科可能适用于特定患者。

研究设计与样本

  • 本文为叙述性综述,讨论分化型甲状腺癌脑转移患者的临床特征、诊断与治疗选择。

主要发现

  • 脑转移可在初始治疗前因症状被发现,但多数患者在随访中因启动酪氨酸激酶抑制剂前影像或神经症状而诊断。
  • 老年男性、滤泡性甲状腺癌、低分化甲状腺癌及远处转移患者发生脑转移的风险可能增加。
  • 增强磁共振成像是检测脑转移的金标准,优于增强计算机断层扫描。
  • 体能状态差的患者适合姑息与支持治疗;神经外科手术通常保留给药物治疗后症状持续者,尤其预后因素良好且病灶较大者,也可考虑用于单发脑转移且手术可及、原发病控制且无其他系统转移者。
  • 立体定向放射外科可能是治疗小病灶的首选,尤其位于脑内不可及区域或不宜手术时;全脑放疗因潜在副作用及疗效争议较少使用,通常保留给多发脑转移且病灶过大不适合立体定向放射外科者。

临床怎么用

  • 不推荐常规筛查脑转移,但老年男性、滤泡性甲状腺癌或低分化甲状腺癌且伴远处转移的患者应仔细评估脑转移。
  • 适合神经外科手术的患者似乎生存获益最高,立体定向放射外科可能适用于特定患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Brain metastases (BM) are the most common intracranial neoplasms in adults and are a significant cause of morbidity and mortality. The brain is an unusual site for distant metastases of thyroid cancer; indeed, the most common sites are lungs and bones. In this narrative review, we discuss about the clinical characteristics, diagnosis, and treatment options for patients with BM from differentiated thyroid cancer (DTC). Summary: BM can be discovered before initial therapy due to symptoms, but in most patients, BM is diagnosed during follow-up because of imaging performed before starting tyrosine kinase inhibitors (TKI) or due to the onset of neurological symptoms. Older male patients with follicular thyroid cancer (FTC), poorly differentiated thyroid cancer (PDTC), and distant metastases may have an increased risk of developing BM. The gold standard for detection of BM is magnetic resonance imaging with contrast agent administration, which is superior to contrast-enhanced computed tomography. The treatment strategies for patients with BM from DTC remain controversial. Patients with poor performance status are candidates for palliative and supportive care. Neurosurgery is usually reserved for cases where symptoms persist despite medical treatment, especially in patients with favorable prognostic factors and larger lesions. It should also be considered for patients with a single BM in a surgically accessible location, particularly if the primary disease is controlled without other systemic metastases. Additionally, stereotactic radiosurgery (SRS) may be the preferred option for treating small lesions, especially those in inaccessible areas of the brain or when surgery is not advisable. Whole brain radiotherapy is less frequently used in treating these patients due to its potential side effects and the debated effectiveness. Therefore, it is typically reserved for cases involving multiple BM that are too large for SRS. TKIs are effective in patients with progressive radioiodine-refractory thyroid cancer and multiple metastases. Conclusions: Although routine screening for BM is not recommended, older male patients with FTC or PDTC and distant metastases may be at higher risk and should be carefully evaluated for BM. According to current data, patients who are suitable for neurosurgery seem to have the highest survival benefit, while SRS may be appropriate for selected patient.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Prinzi A, van Velsen EFS, Belfiore A, et al. Brain Metastases in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis, and Management. Thyroid. 2024. PMID: 39163020. doi:10.1089/thy.2024.0240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。